It depends on your country’s politics of course. What level of care do you want to be publicly funded? I have my doubts that the price can remain this low even if the nonprofit controls the IP. If that IP changes ownership or if the nonprofit prices the drug closer to the market value it will likely change. Edit: Also, the price cannot be contained on the fair market unless competitors who can produce the drug are allowed to exist.
